Vergoeding 2020-2024 voor ATC-subgroep L01X : Overige oncolytica
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023* | 2024* | |
|---|---|---|---|---|---|
| L01XA Platinaverbindingen | 2.012.992 | 2.808.122 | 2.213.021 | 2.113.262 | 1.498.629 |
| L01XB Methylhydrazinen | 122.922 | 124.321 | 131.986 | 122.844 | 71.610 |
| L01XD Sensitizers bij fotodynamische en radiotherapie | 956.894 | 931.632 | 655.919 | 602.172 | 535.564 |
| L01XF Retinoiden bij kanker | 209.270 | 183.111 | 147.417 | 253.010 | 163.198 |
| L01XG Proteasoomremmers | 33.075.439 | 26.329.043 | 19.910.267 | 20.212.215 | 20.741.933 |
| L01XH Hdac-remmers | 4.699 | . | . | . | . |
| L01XJ Hedgehog-signaalroute remmers | 725.718 | 845.785 | 951.287 | 1.367.636 | 1.326.592 |
| L01XK Parp-remmers | 16.125.747 | 28.464.397 | 32.792.264 | 30.772.029 | 24.181.446 |
| L01XL Oncolytische cel- en gentherapie | 20.734.513 | 27.514.784 | 37.756.222 | 33.053.260 | 24.235.836 |
| L01XM Overige oncolytica | . | . | . | 52.647 | 1.383.112 |
| L01XX Overige oncolytica | 14.744.873 | 18.246.505 | 20.879.834 | 24.867.207 | 25.376.304 |
| L01XY Combinaties van oncolytica | 90.008 | 749.083 | 384.126 | 345.183 | 17.004 |
| Totaal | 88.803.077 | 106.196.781 | 115.822.343 | 113.761.465 | 99.531.228 |